Roll Call: IL HB3957 | 2023-2024 | 103rd General Assembly
For additional roll call votes on Illinois HB3957 please see the Vote List
Bill Title: Reinserts the provisions of the introduced bill with the following changes. Sets forth legislative findings. Provides that the Director of Healthcare and Family Services or Director of Central Management Services shall (rather than may) notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the Medical Assistance Program under the Illinois Public Aid Code or a State health plan, respectively, that amounts to price gouging. Provides that a notice sent by the Attorney General to the manufacturer or wholesale drug distributor of an essential off-patent or generic drug shall serve as a litigation hold regarding documents and communications about that drug. Provides that upon petition of the Attorney General, a circuit court may issue an order imposing a civil penalty of up to $10,000 per day (rather than only $10,000) for each violation of the Act or providing for the Attorney General's recovery of costs and disbursements incurred in bringing an action against a manufacturer found to be in violation of the Act. Makes other changes. Effective January 1, 2024.
Spectrum: Partisan Bill (Democrat 76-1)
Status: (Passed) 2023-07-28 - Public Act . . . . . . . . . 103-0367 [HB3957 Detail]
Text: Latest bill text (Chaptered) [HTML]
Bill Title: Reinserts the provisions of the introduced bill with the following changes. Sets forth legislative findings. Provides that the Director of Healthcare and Family Services or Director of Central Management Services shall (rather than may) notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the Medical Assistance Program under the Illinois Public Aid Code or a State health plan, respectively, that amounts to price gouging. Provides that a notice sent by the Attorney General to the manufacturer or wholesale drug distributor of an essential off-patent or generic drug shall serve as a litigation hold regarding documents and communications about that drug. Provides that upon petition of the Attorney General, a circuit court may issue an order imposing a civil penalty of up to $10,000 per day (rather than only $10,000) for each violation of the Act or providing for the Attorney General's recovery of costs and disbursements incurred in bringing an action against a manufacturer found to be in violation of the Act. Makes other changes. Effective January 1, 2024.
Spectrum: Partisan Bill (Democrat 76-1)
Status: (Passed) 2023-07-28 - Public Act . . . . . . . . . 103-0367 [HB3957 Detail]
Text: Latest bill text (Chaptered) [HTML]
Vote: Third Reading in Senate
| Vote | Tally | Democrat | Republican |
|---|---|---|---|
| Yea | 52 | 38 | 14 |
| Nay | 2 | - | 2 |
| Not Voting | 5 | 2 | 3 |
| Absent | - | - | - |
| TOTAL | 59 | 40 | 19 |
